https://doi.org/10.4081/monaldi.2022.2371
Mycobacterium kansasaii and Mycobacterium scrofulaceum dual pulmonary infection in an immunocompetent male: first report from India
Submitted: July 6, 2022
Accepted: October 18, 2022
Published: November 2, 2022
Accepted: October 18, 2022
Abstract Views: 810
PDF: 202
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
A 57-year-old farmer presented with chronic cough and recurrent hemoptysis, previously treated for sputum positive pulmonary tuberculosis. Referred to us for evaluation of drug resistant tuberculosis as his sputum was persistently positive for acid fast bacilli along with radiological worsening even after 6 months of antitubercular treatment. Bronchoalveolar lavage was done and he was diagnosed with a rare mixed non-tuberculous mycobacyteria (NTM) pulmonary infection despite no immune dysfunction. He was successfully treated with multidrug regimen of rifampicin, isoniazid, ethambutol and clarithromycin.
Porvaznik I, Solovič I, Mokrý J. Non-tuberculous mycobacteria: Classification, diagnostics, and therapy. Adv Exp Med Biol 2017;944:19-25.
DOI: https://doi.org/10.1007/5584_2016_45
Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med 2015;36:1-11.
DOI: https://doi.org/10.1016/j.ccm.2014.10.001
Gonzalez-Santiago TM, Drage LA. Nontuberculous mycobacteria: Skin and soft tissue infections. Dermatol Clin 2015;33:563-77.
DOI: https://doi.org/10.1016/j.det.2015.03.017
van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med 2015;36:43-54.
DOI: https://doi.org/10.1016/j.ccm.2014.11.005
Jani MN, Rodrigues CS, Mehta AP. The neglected and often ignored: nontuberculous mycobacteria. J Glob Infect Dis 2011;3:94.
DOI: https://doi.org/10.4103/0974-777X.77305
Sharma SK, Upadhyay V. Non-tuberculous mycobacteria: a disease beyond TB and preparedness in India. Expert Rev Respir Med 2021;15:949-58.
DOI: https://doi.org/10.1080/17476348.2021.1925545
Jain S, Sankar MM, Sharma N, et al. High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB endemic country--experience from a tertiary center in Delhi, India. Pathog Glob Health 2014;108:118-22.
DOI: https://doi.org/10.1179/2047773214Y.0000000133
Shin SH, Jhun BW, Kim SY, et al. Nontuberculous mycobacterial lung diseases caused by mixed infection with Mycobacterium avium complex and Mycobacterium abscessus complex. Antimicrob Agents Chemother 2018;62:e01105-18.
DOI: https://doi.org/10.1128/AAC.01105-18
Kurahara Y, Tachibana K, Tsuyuguchi K, Suzuki K. Mixed pulmonary infection with three types of nontuberculous mycobacteria. Intern Med. 2013;52:507-10.
DOI: https://doi.org/10.2169/internalmedicine.52.8907
Singh AK, Marak RS, Maurya AK, et al. Mixed cutaneous infection caused by Mycobacterium szulgai and Mycobacterium intermedium in a healthy adult female: a rare case report. Case Rep Dermatol Med 2015;2015:607519.
DOI: https://doi.org/10.1155/2015/607519
DeStefano MS, Shoen CM, Cynamon MH. Therapy for Mycobacterium kansasii infection: beyond 2018. Front Microbiol 2018;9:2271.
DOI: https://doi.org/10.3389/fmicb.2018.02271
How to Cite
Ganga, Ranganath T., Pratibha Sharma, Saroj K. Pati, Ajoy K. Behera, and Sunil K. Reddy. 2022. “<em>Mycobacterium kansasaii< em> and <em>Mycobacterium scrofulaceum< em> Dual Pulmonary Infection in an Immunocompetent Male: First Report from India”. Monaldi Archives for Chest Disease 93 (3). https://doi.org/10.4081/monaldi.2022.2371.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Paola Pierucci, Lucrezia De Michele, Maria Luisa de Candia, Federica Barratta, Cesare Gregoretti, Giovanna Elisiana Carpagnano, Giovanni Misseri, SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge , Monaldi Archives for Chest Disease: Early Access
- Rozandeep Kaur, Neha Uppal, Vibha Uppal, Anju Sharma, Impaired glycemic control as a risk factor for reduced lung function in the Indian diabetic population , Monaldi Archives for Chest Disease: Early Access
- Nitin Goel, Nitesh Goyal, Ravishankar Nagaraja , Raj Kumar, Systemic corticosteroids for management of ‘long-COVID’: an evaluation after 3 months of treatment , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- M. Messina, N. Scichilone, F. Guddo, V. Bellia, Rapidly progressive organising pneumonia associated with cytomegalovirus infection in a patient with psoriasis , Monaldi Archives for Chest Disease: Vol. 67 No. 3 (2007): Pulmonary series
- Anastasiia Russkikh, Oleksandr Korotych, Yuliia Sereda, Anastasia Samoilova, Jay Achar, Askar Yedilbayev, Masoud Dara, Irina Vasilyeva, Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Jyoti Kumari, Manish Advani, Gopal Purohit, Correlation of spirometry findings and post-six-minute walk test oxygen desaturation in chronic simple silicosis patients with age, duration of silica exposure, smoking pack years, occupation and mean pulmonary artery pressure , Monaldi Archives for Chest Disease: Early Access
- R.W. Dal Negro, A. Testa, R. Aquilani, S. Tognella, E. Pasini, A. Barbieri, F. Boschi, Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation , Monaldi Archives for Chest Disease: Vol. 77 No. 2 (2012): Pulmonary series
- E. Pozzi, Acebrophylline: an airway mucoregulator and anti-inflammatory agent , Monaldi Archives for Chest Disease: Vol. 67 No. 2 (2007): Pulmonary series
- Fatemeh Khelghati, Fatemeh Nasirpour Seilakhori, Mehdi Goudarzi, Shima Malekloo, Amir Hashem Shahidi Bonjar, Hossein Goudarzi, Mohammad Javad Nasiri, Multidrug-resistant tuberculosis in Iran: a multicenter study , Monaldi Archives for Chest Disease: Early Access
- Shivam Garg, Pratap Upadhya, Arul Kumar, Norton Stephen, Bala Subramanian, Overcoming the challenges of a misdiagnosed rare lung disease – idiopathic pleuroparenchymal fibroelastosis , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
You may also start an advanced similarity search for this article.
